HBV'de Tedavi - EKMUD

Vankomisine Dirençli Enterokok Enfeksiyonları:
Klinik Ne Zaman Kapatılmalı ve Tekrar Ne Zaman Açılmalı
8. Byers KE, Durbin LJ, Simonton BM, Anglim AM, Adal KA,
Farr BM. Disinfection of hospital rooms contaminated
with vancomycin-resistant Enterococcus faecium. Infect
Control Hosp Epidemiol 1998;19:261-4.
9. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health
and economic outcomes of vancomycin-resistant enterococci.
Arch Intern Med 2002; 28;162:2223-8.
10. Chenoweth CE. Enterococcus species. In: Mayhall CG
(ed). Hospital Epidemiology and Infection Control. 3 rd ed.
Philadelphia: Lippincott Williams & Wilkins, 2004:529-44.
11. Comert FB, Kulah C, Aktas E, Ozlu N, Celebi G. First isolation
of vancomycin-resistant enterococci and spread of
a single clone in a university hospital in Northwestern
Turkey. Eur J Clin Microbiol Infect Dis 2007;26:57-61.
12. D’Agatha EMC, Gautam S, Gren WK, Tang YW. High rate
of false negative results of the rectal swab culture method
in detection of gastrointestinal colonization with
vancomycin-resistant enterococci. Clin Infect Dis 2002;
34:167-72.
13. European Antimicrobial Resistance Surveillance System.
Susceptibility results for E. faecium isolates in 2009.
http://www.rivm.nl/earss/database/
14. Falk PS, Winnike J, Woodmansee C, Deasi M, Mayhall
CG. Outbreak of vancomycin-resistant enterococci in a
burn unit. Infect Control Hosp Epidemiol 2000;21:575-82.
15. Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver
DA, Weinstein RA. Reduction in acquisition of vancomycin-resistant
Enterococcus after enforcement of routine
environmental cleaning measures. Clin Infect Dis
2006;42:1552-60.
16. Hota B, Blom DW, Lyle EA, Weinstein RA, Hayden MK.
Interventional evaluation of environmental contamination
by vancomycin-resistant enterococci: failure of personel,
product, or procedure? J Hosp Infect 2009;71:123-
31.
17. Huang SS, Datta R, Platt R. Risk of acquiring antibioticresistant
bacteria from prior room occupants. Arch Intern
Med 2006;166:1945-51.
18. Lai KK, Kelley AL, Melvin ZS, Belliveau PP, Fontecchio SA.
Failure to eradicate vancomycin-resistant enterococci in a
university hospital and the cost of barrier precautions.
Infect Control Hosp Epidemiol 1998;19:647-52.
19. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmidmediated
resistance to vancomycin and teicoplanin in
Enterococcus faecium. N Engl J Med 1988;319:157-61.
20. Livornese LL, Dias S, Samel C, et al. Hospital-acquired
infection with vancomycin-resistant Enterococcus faecium
transmitted by electronic thermometers. Ann Intern
Med 1992;117:112-6.
21. Martinez JA, Ruthazer R, Hansjosten K, Barefoot L,
Syndman DR. Role of environmental contamination as a
risk factor for acquisition of vancomycin-resistant enterococci
by inpatients treated in a medical intensive care
unit. Arch Intern Med 2003;163:1905-12.
22. Morris-Downes M, Smyth EG, Moore J, Thomas T,
Fitzpatrick F, Walsh J, et al. Surveillance and endemic
vancomycin-resistant enterococci: some success in control
is possible. J Hosp Infect 2010;75:228-33.
112
23. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis
WR, Boyce JM, et al. SHEA guideline for preventing nosocomial
transmission of multidrug-resistant strains of S.
Aureus and Enterococcus. Infect Control Hosp Epidemiol
2003;24:362-86.
24. National Nosocomial Infections Surveillance (NNIS) system
report, data summary from January 1992-April 2000,
issued June 2000. Am J Infect Control 2000;28:429-48.
doi: 10.1067/mic.2000.110544.
25. NNIS. Am J Infect Control 2003;31:481-98.
26. Perencevich EN, Fisman DN, Lipsitch M, Haris AD, Morris
JG, Smith D. Projected benefits of active surveillance for
vancomycin-resistant enterococci in ICU settings. Clin
Infect Dis 2004;38:1108-15.
27. Porwancher R, Sheth A, Remphrey S, Taylor E, Hinkle C,
Zervos M. Epidemiological study of hospital acquired
infection with vancomycin-resistant Enterococcus faecium:
possible transmission by an electronic ear-probe
thermometer. Infect Contol Hosp Epidemiol 1997;18:771-3.
28. Recommendations for preventing the spread of vancomycin
resistance recommendations of the Hospital
Infection Control Practices Advisory Committee (HICPAC).
CDC MMWR Recomm Rep 1995;44(RR-12):1-13.
29. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the
Healthcare Infection Control Practices Advisory Comittee.
Management of multidrug-resistant organisms in health
care settings, 2006. Am J Infect Control 2007;35:S165-
93.
30. Slaughter S, Hayden MK, Nathan C, et al. A comparison
of the effect of universal gloves and gowns with that of
glove use alone on acquisition of vancomycin-resistant
enterococci in a medical intensive care unit. Ann Intern
Med 1996;125:448-56.
31. Smith TL, Iwen PC, Olson SB, Rupp ME. Environmental
contamination with vancomycin-resistant enterococci in
an outpatient setting. Infect Control Hosp Epidemiol
1998;19:515-8.
32. Tacconelli E, Cataldo MA. Vancomycin-resistant enterococci
(VRE): transmission and control. Int J Antimicrob
Agents 2008;31:99-106.
33. Tacconelli E, Karchmer AW, Yokoe D, D’Agatha EMC.
Preventing influx of vancomycin-resistant enterococci
into health care institutions by use of a simple validated
prediction rule. Clin Infect Dis 2004;39:964-70.
34. Tornieporth NG, Roberts RB, John J, et al. Risk factors
associated with vancomycin-resistant Enterococcus faecium
infection or colonization in 145 matched case patients
and control patients. Clin Infect Dis 1996;767-72.
35. Wisplinghof H, Bischoff T, Tallent SM, Seifert H, Wenzel RP,
Edmond MB. Nosocomial bloodstream infections in US
hospitals: analysis of 24179 cases from a prospective nationwide
surveillance study. Clin Infect Dis 2004;39:309-17.
3. Türkiye EKMUD Bilimsel Platformu